OptiMAX IGRT is maging module for optical molecular and X-ray image guided radiation therapy research
show detailFast immunoprofiling of T, B, NK and Monocyte
show detailMicsomics
This study investigates the subnuclear organization of the Polycomb repressive complex 2 (PRC2) in triple-negative breast cancer (TNBC) cells, combining in situ proteomics, high-resolution imaging, and functional genomics.
April 14, 2026
Using the Curiox Pluto platform to automate immune profiling, ocrelizumab’s effects in MS reveal repopulation of transitional naïve B cells at 6 months and linked shifts in T/myeloid markers and plasma proteins.
April 7, 2026
Thursday, April 16, 14:00 CET, Riccardo Pasculli, FAS, ACCELA s.r.o.
March 31, 2026
Type of the News
Application | Product news | Scientific paper | Technical breakthrough | Video | Webinar